🔥🐔 BizChicken 🐔🔥

Companies Similar to Rezolute, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

DURECT Corporation

DURECT Corporation logo
Market Cap: Lowest
Employees: Lowest

ALZET

DURECT Corporation is a biopharmaceutical company that develops medicines based on its epigenetic regulator and pharmaceutical programs. It offers products like ALZET osmotic pumps for laboratory animal research, larsucosterol for treating liver diseases, and POSIMIR for post-surgical pain relief.

Tags: ALZET, POSIMIR, biopharmaceutical, epigenetic, larsucosterol, research

Symbol: DRRX

Recent Price: $0.85

Industry: Drug Manufacturers - Specialty & Generic

CEO: Dr. James E. Brown D.V.M.

Sector: Healthcare

Employees: 48

Address: 10260 Bubb Road, Cupertino, CA 95014-4166

Phone: 408 777 1417

Last updated: 2024-12-31

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. logo
Market Cap: High
Employees: Low

rusfertide (PTG-300), PN-943, PN-235

Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.

Tags: biopharmaceutical, blood disorders, hematology, immunomodulatory diseases, inflammatory diseases, peptide-based drugs

Symbol: PTGX

Recent Price: $38.51

Industry: Biotechnology

CEO: Dr. Dinesh V. Patel Ph.D.

Sector: Healthcare

Employees: 125

Address: 7707 Gateway Boulevard, Newark, CA 94560-1160

Phone: 510 474 0170

Last updated: 2024-12-31

NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ZYESAMI, NRX-100, NRX-101

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

Tags: CNS disorders, COVID-19 treatment, bipolar depression, clinical-stage pharmaceutical, pulmonary diseases, suicidal behavior

Symbol: NRXP

Recent Price: $1.53

Industry: Biotechnology

CEO: Dr. Jonathan C. Javitt M.D., M.P.H.

Sector: Healthcare

Employees: 2

Address: 1201 Orange Street, Wilmington, DE 19801

Phone: 484 254 6134

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

ReShape Lifesciences Inc.

ReShape Lifesciences Inc. logo
Market Cap: Lowest
Employees: Lowest

Lap-Band System, Re Shape Vest system, Re Shape Care, Re Shape Diabetes Bloc-Stim Neuromodulation

Re Shape Lifesciences Inc. is a medical device company offering products and services to manage and treat obesity and metabolic diseases globally. Their products include the Lap-Band System, Re Shape Vest system, and Re Shape Care virtual health coaching, among others.

Tags: Lap-Band System, medical device, metabolic diseases, obesity treatment, telehealth

Symbol: RSLS

Recent Price: $4.52

Industry: Medical - Devices

CEO: Mr. Paul F. Hickey

Sector: Healthcare

Employees: 29

Address: 1001 Calle Amanecer, San Clemente, CA 92673

Phone: 949 429 6680

Last updated: 2024-12-31

Revelation Biosciences, Inc.

Revelation Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

REVTx-99b

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.

Tags: allergic rhinitis, biopharmaceutical, clinical trial, diagnostics, immune system therapeutics, kidney disease, nasal congestion, viral infections

Symbol: REVB

Recent Price: $0.39

Industry: Biotechnology

CEO: Mr. James M. Rolke

Sector: Healthcare

Employees: 9

Address: 4660 La Jolla Village Drive, San Diego, CA 92122

Phone: 650-800-3717

Last updated: 2024-12-31

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

REN001

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.

Tags: Clinical Trials, Genetic Disorders, Mitochondrial Diseases, Pharmaceuticals, Therapeutics

Symbol: RPHM

Recent Price: $18.20

Industry: Biotechnology

CEO: Mr. Gregory J. Flesher

Sector: Healthcare

Employees: 8

Address: 18575 Jamboree Road, Irvine, CA 92612

Phone: 619 733 3852

Last updated: 2024-12-31

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

rezafungin acetate

Cidara Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology. Their lead product candidate is rezafungin acetate, a novel echinocandin antifungal for treating invasive fungal infections.

Tags: Cloudbreak platform, anti-infectives, antifungal, biotechnology, infectious diseases, oncology, rezafungin acetate

Symbol: CDTX

Recent Price: $25.25

Industry: Biotechnology

CEO: Dr. Jeffrey L. Stein Ph.D.

Sector: Healthcare

Employees: 69

Address: 6310 Nancy Ridge Drive, San Diego, CA 92121

Phone: 858 752 6170

Last updated: 2024-12-31

Inozyme Pharma, Inc.

Inozyme Pharma, Inc. logo
Market Cap: Medium
Employees: Lowest

INZ-701

Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.

Tags: ABCC6, ENPP1, INZ-701, biopharmaceutical, calciphylaxis, genetic diseases, mineralization, rare diseases, therapeutics

Symbol: INZY

Recent Price: $2.82

Industry: Biotechnology

CEO: Dr. Douglas A. Treco Ph.D.

Sector: Healthcare

Employees: 59

Address: 321 Summer Street, Boston, MA 02210

Phone: 857 330 4340

Leadership

  • Doug Treco, Ph.D., CEO, Chairman of Board of Directors
  • Gayle Gironda, Senior Vice President and Chief People Officer
  • Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
  • Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
  • Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
  • Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
  • Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
  • Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
  • David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
  • Sarah Bhagat, Ph.D., Director
  • Reinaldo M. Diaz, MBA, Director
  • Martin Edwards M.D., MBA, Director
  • Erik Harris, MBA, Director
  • Rob Hopfner, Rph, Ph.D., MBA, Director
  • Edward Mathers, Director
  • Lynne Sullivan, MST, Director

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Regulus Therapeutics Inc.

Regulus Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

RG-012 and RGLS8429

Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.

Tags: biopharmaceutical, clinical stage, drug development, kidney disease, micro RNAs

Symbol: RGLS

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Joseph P. Hagan M.B.A.

Sector: Healthcare

Employees: 30

Address: 4224 Campus Point Court, San Diego, CA 92121

Phone: 858 202 6300

Last updated: 2024-12-31

Relay Therapeutics, Inc.

Relay Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

RLY-4008, RLY-2608, RLY-1971

Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.

Tags: FGFR2, PI3Ka, Src homology, clinical-stage, drug discovery, genetic diseases, oncology, precision medicines, small molecule inhibitors

Symbol: RLAY

Recent Price: $4.18

Industry: Biotechnology

CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS

Sector: Healthcare

Employees: 323

Address: 399 Binney Street, Cambridge, MA 02139

Phone: 617 370 8837

Last updated: 2024-12-31

RenovoRx, Inc.

RenovoRx, Inc. logo
Market Cap: Lowest
Employees: Lowest

Renovo Gem

Renovo Rx, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapies for the treatment of solid tumors, with its lead product candidate, Renovo Gem, in Phase III clinical trials for locally advanced pancreatic cancer.

Tags: Renovo Gem, biopharmaceutical, clinical trials, pancreatic cancer, solid tumors

Symbol: RNXT

Recent Price: $1.39

Industry: Biotechnology

CEO: Mr. Shaun R. Bagai

Sector: Healthcare

Employees: 8

Address: 4546 El Camino Real, Los Altos, CA 94022

Phone: 650 284 4433

Leadership

  • Shaun R. Bagai, Director and Chief Executive Officer
  • Ramtin Agah, MD, Chairman, Chief Medical Officer, and Founder
  • Leesa Gentry, Chief Clinical Officer
  • Ronald B. Kocak, CPA, VP Controller and Principal Accounting Officer
  • Ryan Witt, Senior Vice President, Head of Corporate Strategy and Partnerships
  • Imtiaz Qureshi, MD, Director of Imaging
  • Angela Macfarlane, CEO of Perceive Biotherapeutics, Inc.
  • Laurence J. Marton, MD, Director
  • Una S. Ryan, PhD, OBE, Director
  • Robert J. Spiegel, Director

Last updated: 2024-12-31

Rezolute, Inc.

Rezolute, Inc. logo
Market Cap: Low
Employees: Lowest

RZ358

Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.

Tags: biopharmaceutical, clinical stage, congenital hyperinsulinism, genetic disorder, glucose imbalance, metabolic diseases

Symbol: RZLT

Recent Price: $4.89

Industry: Biotechnology

CEO: Mr. Nevan Charles Elam J.D.

Sector: Healthcare

Employees: 59

Address: 201 Redwood Shores Parkway, Redwood City, CA 94065

Phone: 650 206 4507

Last updated: 2024-12-31

Summit Therapeutics Inc.

Summit Therapeutics Inc. logo
Market Cap: Highest
Employees: Low

ridinilazole

Summit Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to treat infectious diseases, with a lead product candidate called ridinilazole in Phase III clinical trials for Clostridioides difficile infection (CDI).

Tags: Clostridioides difficile, antibiotic, biopharmaceutical, clinical trials, infectious diseases

Symbol: SMMT

Recent Price: $17.89

Industry: Biotechnology

CEO: Mr. Robert W. Duggan

Sector: Healthcare

Employees: 105

Address: One Broadway, Cambridge, MA 02142

Phone: 617 514 7149

Leadership

  • Bob Duggan, CEO & Chairman
  • Dr. Maky Zanganeh, CEO & President
  • Dave Gancarz, Chief Business & Strategy Officer
  • Dr. Urte Gayko, Chief Regulatory, Quality & Pharmacovigilance Officer
  • Dr. Fong Clow, Chief Biometrics Officer
  • Shelley D Spray, Chief Education & Brand Officer
  • Dr. Allen S. Yang, Chief Medical Officer
  • Bhaskar Anand, Head of Finance and Chief Accounting Officer
  • Dr. Betty Chang, Head of Research, Oncology & Inflammation
  • Dr. Andy Dwyer, Head of CMC & Supply Chain
  • Dr. Noam Frey, SVP, Global Medical Affairs
  • Pawan Parihar, Head of Information Technology
  • Dr. Juthamas Sukbuntherng, Head of Clinical Pharmacology & DMPK
  • Robert W. Duggan, CEO & Chairman of the Board
  • Dr. Mahkam (Maky) Zanganeh, CEO, President & Director
  • Manmeet Soni, Chief Operating Officer, Chief Financial Officer & Director
  • Kenneth A. Clark, Lead Independent Director
  • Dr. Robert Booth, Non-Executive Director
  • Dr. Alessandra Cesano, Non-Executive Director
  • Dr. Yu (Michelle) Xia, Director
  • Dr. Mostafa Ronaghi, Non-Executive Director
  • Jeff Huber, Non-Executive Director

Last updated: 2024-12-31

Zura Bio Limited

Zura Bio Limited logo
Market Cap: Low
Employees: Lowest

ZB-168

Zura Bio Limited is a clinical-stage biotechnology company based in San Diego, California, focusing on developing novel medicines for immune and inflammatory disorders.

Tags: biotechnology, clinical-stage, immune disorders, inflammatory disorders, novel medicines

Symbol: ZURA

Recent Price: $2.55

Industry: Biotechnology

CEO: Mr. Robert Lisicki

Sector: Healthcare

Employees: 14

Address: 4225 Executive Square, San Diego, CA 92037

Phone: 858 247 0520

Last updated: 2024-12-31

Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Renazorb, UNI 494

Unicycive Therapeutics is a biotech company developing novel therapies for kidney diseases in the United States, focusing on treatments for hyperphosphatemia and acute kidney injury.

Tags: Renazorb, UNI 494, acute kidney injury, biotechnology, hyperphosphatemia, kidney diseases

Symbol: UNCY

Recent Price: $0.58

Industry: Biotechnology

CEO: Dr. Shalabh K. Gupta M.D., MPA

Sector: Healthcare

Employees: 14

Address: 4300 El Camino Real, Los Altos, CA 94022

Phone: 650 351 4495

Last updated: 2024-11-08

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

resmetirom

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.

Tags: biopharmaceutical, cardiovascular, clinical-stage, liver diseases, metabolic, non-alcoholic steatohepatitis, resmetirom, therapeutic candidates

Symbol: MDGL

Recent Price: $311.62

Industry: Biotechnology

CEO: Mr. William J. Sibold

Sector: Healthcare

Employees: 376

Address: Four Tower Bridge, West Conshohocken, PA 19428

Phone: 267 824 2827

Leadership

  • BILL SIBOLD, Chief Executive Officer
  • REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
  • MARDI C. DIER, Chief Financial Officer
  • CAROLE HUNTSMAN, Chief Commercial Officer
  • CLINT WALLACE, Chief Human Resources Officer
  • RONALD FILIPPO, Chief Information Officer
  • STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
  • SHANNON KELLEY, General Counsel
  • MARK BARRETT, Chief Business Officer
  • MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
  • Julian C. Baker, Chairman and Director
  • Kenneth M. Bate, Director
  • Raymond Cheong, M.D., Ph.D., Director
  • Fred Craves, Ph.D., Director
  • James M. Daly, Director
  • Paul A. Friedman, M.D., Director
  • Richard S. Levy, M.D., Director
  • Bill Sibold, Director, Chief Executive Officer
  • Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

VTX958

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.

Tags: VTX002, VTX2735, VTX958, autoimmune disorders, biopharmaceutical, clinical trials, inflammatory diseases, small molecule

Symbol: VTYX

Recent Price: $2.23

Industry: Biotechnology

CEO: Dr. Raju S. Mohan Ph.D.

Sector: Healthcare

Employees: 73

Address: 662 Encinitas Boulevard, Encinitas, CA 92024

Phone: 760 593 4832

Last updated: 2024-12-31